Source:http://linkedlifedata.com/resource/pubmed/id/20558149
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:dateCreated |
2010-7-29
|
pubmed:abstractText |
The amyloid beta-protein (Abeta)-induced complement system activation plays an important role in Alzheimer's disease (AD). Complement receptor 1 (CR1) is thought to contribute to Abeta clearance. A recent large genome-wide association study (GWAS) has identified significant association of two single nucleotide polymorphisms (SNPs) (rs6656401 and rs3818361) in the CR1 gene with AD in Caucasians. Here, we performed a case-control study to clarify whether the risk for sporadic late-onset AD (LOAD) might be influenced by these polymorphisms in a large Chinese cohort consisting of 254 patients and 357 healthy controls. The results revealed that there were significant differences in genotype (P=0.02) and allele (P=0.007) frequencies of the SNP rs6656401 but no in rs3818361 between AD patients and controls. The A allele of rs6656401 was associated with an increased risk of LOAD (P=0.007, odds ratios/OR =1.652). In the subgroup of APOE epsilon4 non-carriers, both the A of rs6656401 and T allele of rs3818361 were observed to be significantly higher in case than in controls (P=0.002 and P=0.035, respectively). For rs6656401, the logistic regression analysis revealed that the (AA +AG) genotypes has a 2.4-fold increased risk compared with the GG genotype (P=0.049). Haplotype analysis identified the AT haplotype to increase the risk of LOAD (P=0.03, OR=2.44). This study provides the evidence that variations in the CR1 gene play an important role in the pathogenesis of sporadic LOAD in the Han Chinese population.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
1872-6240
|
pubmed:author | |
pubmed:copyrightInfo |
Copyright 2010 Elsevier B.V. All rights reserved.
|
pubmed:issnType |
Electronic
|
pubmed:day |
12
|
pubmed:volume |
1348
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
216-21
|
pubmed:meshHeading |
pubmed-meshheading:20558149-Aged,
pubmed-meshheading:20558149-Aged, 80 and over,
pubmed-meshheading:20558149-Alzheimer Disease,
pubmed-meshheading:20558149-Apolipoproteins E,
pubmed-meshheading:20558149-Case-Control Studies,
pubmed-meshheading:20558149-China,
pubmed-meshheading:20558149-Female,
pubmed-meshheading:20558149-Gene Frequency,
pubmed-meshheading:20558149-Genetic Predisposition to Disease,
pubmed-meshheading:20558149-Genotype,
pubmed-meshheading:20558149-Humans,
pubmed-meshheading:20558149-Male,
pubmed-meshheading:20558149-Odds Ratio,
pubmed-meshheading:20558149-Polymorphism, Single Nucleotide,
pubmed-meshheading:20558149-Receptors, Complement,
pubmed-meshheading:20558149-Risk Factors
|
pubmed:year |
2010
|
pubmed:articleTitle |
Complement receptor 1 polymorphisms and risk of late-onset Alzheimer's disease.
|
pubmed:affiliation |
Department of Neurology, Qingdao Municipal Hospital, School of Medicine, Qingdao University, Qingdao, Shandong Province 266071, PR China.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|